JP2013520977A5 - - Google Patents

Download PDF

Info

Publication number
JP2013520977A5
JP2013520977A5 JP2012555424A JP2012555424A JP2013520977A5 JP 2013520977 A5 JP2013520977 A5 JP 2013520977A5 JP 2012555424 A JP2012555424 A JP 2012555424A JP 2012555424 A JP2012555424 A JP 2012555424A JP 2013520977 A5 JP2013520977 A5 JP 2013520977A5
Authority
JP
Japan
Prior art keywords
parvovirus
recombinant
attenuated
capsid protein
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012555424A
Other languages
English (en)
Japanese (ja)
Other versions
JP6200155B2 (ja
JP2013520977A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/053164 external-priority patent/WO2011107534A1/en
Publication of JP2013520977A publication Critical patent/JP2013520977A/ja
Publication of JP2013520977A5 publication Critical patent/JP2013520977A5/ja
Application granted granted Critical
Publication of JP6200155B2 publication Critical patent/JP6200155B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012555424A 2010-03-05 2011-03-03 組換え弱毒化パルボウイルス Active JP6200155B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US31103210P 2010-03-05 2010-03-05
EP10155646.2 2010-03-05
EP10155646 2010-03-05
US61/311,032 2010-03-05
PCT/EP2011/053164 WO2011107534A1 (en) 2010-03-05 2011-03-03 Recombinant attenuated parvovirus

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015200216A Division JP6346143B2 (ja) 2010-03-05 2015-10-08 組換え弱毒化パルボウイルス

Publications (3)

Publication Number Publication Date
JP2013520977A JP2013520977A (ja) 2013-06-10
JP2013520977A5 true JP2013520977A5 (enExample) 2013-11-07
JP6200155B2 JP6200155B2 (ja) 2017-09-20

Family

ID=42562704

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2012555424A Active JP6200155B2 (ja) 2010-03-05 2011-03-03 組換え弱毒化パルボウイルス
JP2015200216A Active JP6346143B2 (ja) 2010-03-05 2015-10-08 組換え弱毒化パルボウイルス
JP2018072318A Pending JP2018134088A (ja) 2010-03-05 2018-04-04 組換え弱毒化パルボウイルス

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2015200216A Active JP6346143B2 (ja) 2010-03-05 2015-10-08 組換え弱毒化パルボウイルス
JP2018072318A Pending JP2018134088A (ja) 2010-03-05 2018-04-04 組換え弱毒化パルボウイルス

Country Status (10)

Country Link
US (1) US9234182B2 (enExample)
EP (1) EP2542260B1 (enExample)
JP (3) JP6200155B2 (enExample)
CN (1) CN102791288B (enExample)
AU (1) AU2011222910B2 (enExample)
CA (1) CA2790653C (enExample)
DK (1) DK2542260T3 (enExample)
ES (1) ES2566033T3 (enExample)
RU (1) RU2527157C2 (enExample)
WO (1) WO2011107534A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2790653C (en) * 2010-03-05 2019-02-19 Intervet International B.V. Recombinant attenuated parvovirus
US9314519B2 (en) 2012-08-21 2016-04-19 Intervet Inc. Liquid stable virus vaccines
US20140234354A1 (en) * 2013-02-15 2014-08-21 Boehringer Ingelheim Vetmedica, Inc. Porcine parvovirus 5b, methods of use and vaccine
AR097762A1 (es) 2013-09-27 2016-04-13 Intervet Int Bv Formulaciones secas de vacunas que son estables a temperatura ambiente
CN105263953B (zh) * 2014-01-15 2020-01-07 勃林格殷格翰动物保健美国有限公司 猪细小病毒5a、使用方法及疫苗
ES2771850T3 (es) 2014-04-17 2020-07-07 Intervet Int Bv Parvovirus porcino
EA201991065A1 (ru) 2016-11-03 2019-11-29 Вакцина против свиного парвовируса
AU2017353380B2 (en) 2016-11-03 2024-08-22 Boehringer Ingelheim Vetmedica Gmbh Vaccine against porcine parvovirus and porcine reproductive and respiratory syndrome virus and methods of production thereof
WO2022096472A1 (en) 2020-11-04 2022-05-12 Intervet International B.V. Canine parvovirus
CN114957406B (zh) * 2022-05-26 2024-02-02 吉林大学 一种犬细小病毒的三价抗原和三价病毒样颗粒以及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8502399D0 (en) * 1985-01-31 1985-03-06 Akzo Nv Canine parvovirus vaccines
ATE454445T1 (de) * 1998-11-10 2010-01-15 Univ North Carolina Virusvektoren und verfahren für ihre herstellung und verabreichung.
ATE496629T1 (de) * 2005-07-28 2011-02-15 Pfizer Prod Inc Impfstoff gegen felines calicivirus (fcv), der ein fcv kapsid protein oder ein isoliertes fcv kapsid protein mit der protein sequenz seq id no: 13 oder mit einer protein sequenz, die zumindestens zu 95 identisch zur seq id no: 13 ist enthält.
NZ614571A (en) * 2007-06-14 2014-12-24 Univ Oklahoma State Vaccines containing canine parvovirus genetic variants
CA2790653C (en) * 2010-03-05 2019-02-19 Intervet International B.V. Recombinant attenuated parvovirus

Similar Documents

Publication Publication Date Title
RU2012142309A (ru) Рекомбинантный аттенуированный парвовирус
Moller-Tank et al. Phosphatidylserine receptors: enhancers of enveloped virus entry and infection
Han et al. Engineering the PRRS virus genome: updates and perspectives
MX372992B (es) Vector de virus adeno-asociado.
EA201492202A1 (ru) Способ экспрессии гетерологичных белков с использованием рекомбинантного вирусного вектора с минус-нитью рнк
WO2013049121A3 (en) Recombinant phage and methods
JP2019530466A5 (enExample)
EA201791343A1 (ru) Композиции и способы для конструирования вирусного генома in vitro
ES2623149T3 (es) Parvovirus atenuado vivo
HRP20201324T1 (hr) Vektori aav koji sadrže faktor viii koji kodira gen
JP2013048638A5 (enExample)
RU2008101367A (ru) Способы и композиции для экспрессии отрицательной смысловой вирусной рнк в собачьих клетках
WO2010118188A3 (en) Production of an intact virus in a non-host cell system using a secondary host viral construct
JP2015517304A5 (enExample)
WO2010118205A3 (en) Production of an intact virus in a mammalian (non-host) cell system using a secondary non-host viral construct
MX387420B (es) Producción de virus en cultivos celulares.
PH12020552252A1 (en) Influenza virus hemagglutinin mutants
WO2014122629A3 (en) Improved baculoviral expression system and methods of producing the same
CN104561092A (zh) 表达猪瘟病毒e2蛋白重组prrs病毒基因工程疫苗的构建方法和应用
WO2013030176A3 (en) Live attenuated influenza virus
CL2008003821A1 (es) Metodo para producir el virus de la estomatitis vesicular (vsv) atenuado en celulas, que comprende: a) proporcionar una celula que comprende un gen g vsv optimizado e inducible, b) inducir la celula a expresar dicho gen, c) infectar la celula con un vsv atenuado, d) hacer crecer dichas celulas, y e) recuperar el vsv atenuado
CN104911152B (zh) 一株重组传染性造血器官坏死病毒rIHNV HLJ‑09株及其构建方法和应用
JP2013531967A5 (enExample)
BR112014006794A2 (pt) vetores com base em vírus da tristeza dos citros para expressão de gene/s estranho/s
CN103695465A (zh) 猪繁殖与呼吸综合征病毒疫苗株cDNA感染性克隆及其应用